Malawi

in page functions
[French]
Malawi
Total population (2017) 18,298,666
Birth cohort (2017) 692,291
Surviving Infants (surviving to 1 year per year, 2017) 656,296
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 43/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 64/1000
World Bank Index, IDA (2015) 3.15
Gross Nation Income (per capita US$, 2015) 340
Co-financing group (2017) Initial self-financing
No. of districts/territories (2016) 28

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Malawi

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $218,065,223 $268,232,127 $207,149,592
Cash Support (CASHSUPP) $197,000 $197,000 $172,000 87%
Cold Chain Equipment Optimisation Platform (CCEOP) $2,369,630 $4,481,534
Health system strengthening (HSS 1) $11,002,375 $11,002,375 $11,002,375 100%
Health system strengthening (HSS 2) N/A
HPV (NVS) $2,193,000 $7,927,000
HPV Demo (NVS) $475,773 $475,773 $339,895 71%
HPV MAC (NVS) $9,954,500 $9,954,500
HPV MAC - Op costs (OPC) $733,500 $733,500
Immunisation services support (ISS) $1,986,000 $1,986,000 $1,986,000 100%
Injection Safety Devices (NVS) $441,500 $1,256,000 $273,706 62%
Injection safety support (INS) $722,509 $722,509 $722,509 100%
IPV (NVS) $75,039 $75,039 $57,964 77%
Measles (NVS) $659,215 $659,215 $664,424 101%
Measles-Rubella (NVS) $6,410,000 $6,410,000 $6,490,140 101%
MR - Operational costs (OPC) $5,030,349 $5,030,349 $5,030,349 100%
Penta (NVS) $91,253,569 $98,865,069 $90,240,564 99%
Pneumo (NVS) $65,147,342 $89,672,842 $71,359,430 110%
Product Switch Grant (PSG) $182,500 $182,500 $182,289 100%
Rotavirus (NVS) $15,967,433 $25,336,933 $16,023,458 100%
Vaccine Introduction Grant (VIG) $3,263,989 $3,263,989 $2,604,489 80%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Malawi DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 84%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2013) 92.30%
Household survey: DTP3 coverage for female (2013) 92.90%
Household survey: Last DTP3 survey (2013) 93%
% districts achieving > 80% DTP3 coverage (2016) 68%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 81%

Breakdown of support

Non-vaccine support Vaccine support
10% 90%
$21,700,011 $185,449,581

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Malawi

26 October 2017

Malawi MR 2017

24 October 2017

Aspen statement - Gavi CEO Seth Berkley and Peggy Clark, ED, Aspen Global Innovators Group

Gavi and the Aspen Institute to strengthen health management capacity in developing countries

Malawi will be the first country to benefit from the new partnership .

11 July 2017

Inky fingers point to healthy future for Malawi's children

Usually parents are quick to ask children to scrub their inky fingers – but not after a recent life-saving vaccination campaign in Malawi. Close to 8 million children’s fingers were marked with an ink stain to show that they had been immunised against two deadly diseases – measles and rubella.

close icon

modal window here